Eli Lilly

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Eli Lilly and other ETFs, options, and stocks.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The firm's products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies.

CEO

David A. Ricks

CEODavid A. Ricks

Employees

35,000

Employees35,000

Headquarters

Indianapolis, Indiana

HeadquartersIndianapolis, Indiana

Founded

1876

Founded1876

Employees

35,000

Employees35,000

LLY Key Statistics

Market cap

343.54B

Market cap343.54B

Price-Earnings ratio

52.53

Price-Earnings ratio52.53

Dividend yield

1.12

Dividend yield1.12

Average volume

2.73M

Average volume2.73M

High today

$352.18

High today$352.18

Low today

$346.75

Low today$346.75

Open price

$350.86

Open price$350.86

Volume

2.57M

Volume2.57M

52 Week high

$384.44

52 Week high$384.44

52 Week low

$231.87

52 Week low$231.87

LLY News

CNBC 7h

Jim Cramer's Investing Club meeting Thursday: Stocks rise, Eli Lilly, Meta

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Thursday's key moments. Continue...

Yahoo Finance 9h

Lilly Supports Direct Relief’s Efforts To Expand Access to Medicines by Improving Cold Chain Capacity - Yahoo Finance

INDIANAPOLIS, IN and SANTA BARBARA, CA / ACCESSWIRE / January 26, 2023 / Direct Relief: Eli Lilly and Company (NYSE:LLY) and Direct Relief today announced a ne...

Benzinga 1d

Here's How Much $1000 Invested In Eli Lilly 15 Years Ago Would Be Worth Today - Benzinga

Eli Lilly LLY has outperformed the market over the past 15 years by 6.23% on an annualized basis producing an average annual return of 13.61%. Currently, Eli Li...

Analyst ratings

71%

of 24 ratings

Buy

70.8%

Hold

29.2%

Sell

LLY Earnings

$0.00

$0.87

$1.75

$2.62

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

$1.92 per share

Estimated$1.92 per share

Actual

Available Feb 2, Pre-Market

ActualAvailable Feb 2, Pre-Market

More LLY News

Barron's 2d

Eli Lilly, Novo Nordisk Get a Share-Price Pop From Weight-Loss Drugs

Text size Two of last year’s strongest drug stocks were energized by weight loss. While the overall equity market sagged in 2022, Eli Lilly (ticker: LLY) rose...

Yahoo Finance 2d

Eli Lilly Gains As Market Dips: What You Should Know - Yahoo Finance

In the latest trading session, Eli Lilly (LLY) closed at $346.39, marking a +1.22% move from the previous day. The stock outpaced the S&P 500's daily loss of 0....

Reuters 2d

Eli Lilly to invest $450 mln more to expand capacity as obesity drug ... - Reuters

Jan 24 (Reuters) - Eli Lilly and Co plans to invest an additional $450 million to expand capacity of a plant in North Carolina, the U.S. drugmaker...

Benzinga 2d

Another Year of Blockbuster Drug and Treatment Approvals Possible in 2023 - Benzinga

The United States Food and Drug Administration (FDA) approved 45 new drugs in 2022.1 Though the number of approvals was the lowest since 2016, nearly half of th...

Bloomberg 2d

Eli Lilly Plans Manufacturing Expansion as Obesity Drug Demand ... - Bloomberg

Eli Lilly & Co. will spend $450 million to expand a manufacturing site in North Carolina as demand grows for its diabetes drug that also has the potential to tr...

Reuters 3d

Eli Lilly to invest $450 mln to expand diabetes drug plant capacity

Jan 24 (Reuters) - Eli Lilly and Co said on Tuesday it plans to invest an additional $450 million to expand its manufacturing capacity at the Research Triangle...

MarketWatch 3d

Eli Lilly to invest additional $450 million in Research Triangle Park facility, to add at least 100 jobs

Eli Lilly & Co. LLY, -1.12% said Tuesday it’s planning to invest an additional $450 million in a manufacturing site at Research Triangle Park in North Carolina...